Neurovalens Targets Further Growth In America With Funding Boost

Neurovalens Targets Further Growth In America With Funding Boost

Andrew Kelly Corporate

Belfast-based global health-tech company Neurovalens has received £750,000 from the Growth Finance Fund.  The funding will support the launch of the company’s new sleep product in the USA later this year. Finance for the £30m Growth Finance Fund has been provided by the British Business Bank, Invest Northern Ireland and private investors, Northern Ireland Local Government Officers’ Superannuation Committee (NILGOSC). …